CD274 and non-small cell lung carcinoma: Suresh et al. found that inhibition of heme synthesis leads to HRI activation that enhances PD-L1 translation in NSCLC cells, which can be utilized to sensitize NSCLC to PD-L1 antibody treatment [40].